BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sayitoglu EC, Freeborn RA, Roncarolo MG. The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application. Front Immunol 2021;12:693105. [PMID: 34177953 DOI: 10.3389/fimmu.2021.693105] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Hippen KL, Hefazi M, Larson JH, Blazar BR. Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease. Front Immunol 2022;13:926550. [DOI: 10.3389/fimmu.2022.926550] [Reference Citation Analysis]
2 Bellinghausen I, Khatri R, Saloga J. Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation. Front Immunol 2022;13:912529. [PMID: 35720406 DOI: 10.3389/fimmu.2022.912529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li R, Wang R, Zhong S, Asghar F, Li T, Zhu L, Zhu H. TGF-β1-overexpressing mesenchymal stem cells reciprocally regulate Th17/Treg cells by regulating the expression of IFN-γ. Open Life Sci 2021;16:1193-202. [PMID: 34761110 DOI: 10.1515/biol-2021-0118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Hefazi M, Bolivar-Wagers S, Blazar BR. Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges. Int J Mol Sci 2021;22:9676. [PMID: 34575843 DOI: 10.3390/ijms22189676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]